199 related articles for article (PubMed ID: 7216470)
1. Effects of muramyl dipeptide treatment on resistance to infection with Toxoplasma gondii in mice.
Krahenbuhl JL; Sharma SD; Ferraresi RW; Remington JS
Infect Immun; 1981 Feb; 31(2):716-22. PubMed ID: 7216470
[TBL] [Abstract][Full Text] [Related]
2. Effects of treatment with muramyl dipeptide and certain of its analogs on resistance to Listeria monocytogenes in mice.
Humphres RC; Henika PR; Ferraresi RW; Krahenbuhl JL
Infect Immun; 1980 Nov; 30(2):462-6. PubMed ID: 7439991
[TBL] [Abstract][Full Text] [Related]
3. Effects of muramyl dipeptide and trehalose dimycolate on resistance of mice to Toxoplasma gondii and Acanthamoeba culbertsoni infections.
Masihi KN; Bhaduri CR; Werner H; Janitschke K; Lange W
Int Arch Allergy Appl Immunol; 1986; 81(2):112-7. PubMed ID: 3759255
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cytotoxic and microbicidal function of bronchoalveolar and peritoneal macrophages.
Ryning FW; Krahenbuhl JL; Remington JS
Immunology; 1981 Apr; 42(4):513-9. PubMed ID: 7239556
[TBL] [Abstract][Full Text] [Related]
5. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
Leclerc C; Juy D; Bourgeois E; Chedid L
Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275
[No Abstract] [Full Text] [Related]
6. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
7. Recent developments concerning muramyl dipeptide, a synthetic immunoregulating molecule.
Chedid L; Carelli C; Audibert F
J Reticuloendothel Soc; 1979 Dec; 26(Suppl):631-41. PubMed ID: 392087
[No Abstract] [Full Text] [Related]
8. Marked enhancement in vivo of adjuvant activity of muramyl dipeptide to protein antigens and to synthetic weak immunogens with monoclonal anti-muramyl dipeptide antibodies.
Bahr GM; Tello DS; Chedid LA
Infect Immun; 1985 Aug; 49(2):312-9. PubMed ID: 4018873
[TBL] [Abstract][Full Text] [Related]
9. Activation of mouse peritoneal adherent cells with N-acyl muramyl dipeptide derivatives.
Nishimura K; Okumura H; Saiki I; Okuyama H; Azuma I
Infect Immun; 1985 Mar; 47(3):665-9. PubMed ID: 3882562
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.
Fraser-Smith EB; Matthews TR
Infect Immun; 1981 Dec; 34(3):676-83. PubMed ID: 7333666
[TBL] [Abstract][Full Text] [Related]
11. Biological activities of muramyl dipeptide, a synthetic glycopeptide analogous to bacterial immunoregulating agents.
Chedid L; Audibert F; Johnson AG
Prog Allergy; 1978; 25():63-105. PubMed ID: 362430
[No Abstract] [Full Text] [Related]
12. Failure of synthetic muramyl dipeptide to increase antibacterial resistance.
Finger H; Wirsing von König CH
Infect Immun; 1980 Feb; 27(2):288-91. PubMed ID: 6155329
[TBL] [Abstract][Full Text] [Related]
13. Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity.
Chedid LA; Parant MA; Audibert FM; Riveau GJ; Parant FJ; Lederer E; Choay JP; Lefrancier PL
Infect Immun; 1982 Feb; 35(2):417-24. PubMed ID: 7035362
[TBL] [Abstract][Full Text] [Related]
14. Effects of adjuvants and Toxoplasma gondii antigens on immune response and outcome of peroral T. gondii challenge.
McLeod R; Estes RG; Mack DG
Trans R Soc Trop Med Hyg; 1985; 79(6):800-4. PubMed ID: 3832492
[TBL] [Abstract][Full Text] [Related]
15. Immunoadjuvant activity of synthetic N-acetyl muramyl dipeptide.
Masek K; Zaoral M; Jezek J; Straka R
Experientia; 1978 Oct; 34(10):1363-4. PubMed ID: 738426
[No Abstract] [Full Text] [Related]
16. CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells.
Hakim FT; Gazzinelli RT; Denkers E; Hieny S; Shearer GM; Sher A
J Immunol; 1991 Oct; 147(7):2310-6. PubMed ID: 1918963
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of mouse resistance to bacterial infection with muramyl dipeptide glycoside.
Kalyuzhin OV; Kalina NG; Bashtanenko AF; Shkalev MV; Kuzovlev FN; Kalyuzhin VV
Bull Exp Biol Med; 2003 May; 135(5):452-5. PubMed ID: 12910284
[TBL] [Abstract][Full Text] [Related]
18. Effects of muramyl dipeptide on superoxide anion release and on anti-microbial activity of human macrophages.
Wilson CB; Bohnsack J; Weaver WM
Clin Exp Immunol; 1982 Aug; 49(2):371-6. PubMed ID: 6290115
[TBL] [Abstract][Full Text] [Related]
19. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E
Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554
[TBL] [Abstract][Full Text] [Related]
20. Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptide.
Taniyama T; Holden HT
Cell Immunol; 1979 Dec; 48(2):369-74. PubMed ID: 228871
[No Abstract] [Full Text] [Related]
[Next] [New Search]
